Performance properties, lactic acid specific migration and swelling by simulant of biodegradable poly(lactic acid)/nanoclay multilayer films for food packaging.

The aim of the study was the development of a multifunctional, high-performance, fully biodegradable multilayer polylactic acid (PLA) film for food packaging applications. In particular, sealable multilayer PLA-clay nanocomposite systems with different layouts in terms of composition and relative thickness of the layers, all consisting of a PLA-clay nanocomposite layer between two pure PLA layers for direct food contact, were designed and produced by blown film co-extrusion. The films obtained were analysed for their morphology, functional properties and lactic acid (LA)-specific migration in 50% ethanol. The results showed that, with respect to the unfilled multilayer system, taken as a reference, the nanocomposite films had significant improvements, up to about 40%, in their barriers to oxygen and tensile strengths, and resulted in being more easily sealable over a wide heat-sealing temperature range (80-100°C) with higher seal strength. Moreover, all films had LA migrations always well below the former generic overall migration limit of 60 mg kg-1 food (10 mg dm-2) of European Union Regulation No. 10/2011 (deleted by the amending Regulation No. 2016/1416), even if their morphology was strongly modified during the migration tests due to the strong swelling action of the used simulant (simulant D1 = 50% ethanol (aq.) (v/v)) towards PLA.

SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B.

A proper balance between saturated and unsaturated fatty acids (FAs) is required for maintaining cell homeostasis. The increased demand of FAs to assemble the plasma membranes of continuously dividing cancer cells might unbalance this ratio and critically affect tumour outgrowth. We unveiled the role of the stearoyl-CoA desaturase SCD5 in converting saturated FAs into mono-unsaturated FAs during melanoma progression. SCD5 is down-regulated in advanced melanoma and its restored expression significantly reduced melanoma malignancy, both in vitro and in vivo, through a mechanism governing the secretion of extracellular matrix proteins, such as secreted protein acidic and rich in cysteine (SPARC) and collagen IV and of their proteases, such as cathepsin B. Enforced expression of SCD5 or supplementation of its enzymatic product, oleic acid, reduced the intracellular pH (pHe > pHi) and, in turn, vesicular trafficking across plasma membranes as well as melanoma dissemination. This intracellular acidification appears also to depend on SCD5-induced reduction of the C2 subunit of the vacuolar H(+) -ATPase, a proton pump whose inhibition changes the secretion profile of cancer cells. Our data support a role for SCD5 and its enzymatic product, oleic acid, in protection against malignancy, offering an explanation for the beneficial Mediterranean diet. Furthermore, SCD5 appears to functionally connect tumour cells and the surrounding stroma toward modification of the tumour microenvironment, with consequences on tumour spread and resistance to treatment.